| Name | Title | Contact Details |
|---|
For more than 130 years, Carstens has focused on the specific and evolving needs of healthcare professionals - providing revolutionary solutions that transform clinical environments, enhance patient experiences and positively impact results. The first to bring patient information to the point of care, we have always been passionate about connecting with the human side of healthcare. Today, we continue to lead the industry with our inventive product development - bringing new solutions to new demands for more efficient, productive and interactive care. Carstens - connecting with the human side of healthcare.
Furiex Pharmaceuticals, Inc., a drug development company, engages in the compound partnering business primarily in the United States. It collaborates with pharmaceutical and biotechnology companies to enhance the value of their drug candidates by applying its novel approach to drug development. The company’s products under development include Eluxadoline1, a mu opioid receptor agonist and delta opioid receptor antagonist, which is in Phase III clinical trials for the treatment of diarrhea-predominant irritable bowel syndrome; and Avarofloxacin1, a Phase III-ready fluoroquinolone antibiotic for the treatment of acute bacterial skin and skin structure infections. It is also developing SYR-472, which is in Phase III clinical trials for the treatment of Type-2 diabetes. In addition, the company has rights to compounds in various stages of development and commercialization, which includes Nesina, Liovel, Oseni, and Kazano for the treatment of Type-2 diabetes, as well as Priligy for the treatment of premature ejaculation. The company was founded in 1998 and is headquartered in Morrisville, North Carolina.
Nussentials is a Eufaula, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Jewish Community Center of Charlotte, NC
Atritech is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.